Expertise in
18
conditions

Dr. Lijo John

Oncology
Longview Cancer Center Mobile Pet
1300 N 4th St, 
Longview, TX 
Accepting New Patients
Offers Telehealth
Expertise in
18
conditions
Longview Cancer Center Mobile Pet
1300 N 4th St, 
Longview, TX 

Overview

Lijo John is an Oncologist practicing medicine in Longview, Texas.

Dr. John is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Familial Colorectal Cancer, and Colorectal Cancer.

He is actively involved in clinical research, co-authoring 3 peer reviewed articles and participating in 4 clinical trials. Dr. John is currently accepting new patients.

Specialties

Oncology

Hospital Affiliations

Christus Good Shepherd Medical Center
Longview Regional Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Longview Cancer Center Mobile Pet
1300 N 4th St, Longview, TX 75601

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 07, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Abiraterone Acetate, Prednisone
Study Phase: Phase 2/Phase 3
A Phase 2, Randomized, Open-Label Study of Trilaciclib Administered With First-Line Platinum-Based Chemotherapy and Avelumab Maintenance Therapy in Patients With Untreated, Locally Advanced or Metastatic Urothelial Carcinoma (PRESERVE 3)
A Phase 2, Randomized, Open-Label Study of Trilaciclib Administered With First-Line Platinum-Based Chemotherapy and Avelumab Maintenance Therapy in Patients With Untreated, Locally Advanced or Metastatic Urothelial Carcinoma (PRESERVE 3)
Enrollment Status: Terminated
Publish Date: September 08, 2025
Intervention Type: Drug
Study Drugs: Trilaciclib, Gemcitabine, Cisplatin, Carboplatin, Avelumab
Study Phase: Phase 2
A Phase 2 Open-label Study of Brentuximab Vedotin in Front-line Therapy of Hodgkin Lymphoma (HL) an dCD30-expressing Peripheral T-cell Lymphoma (PTCL) in Older Patients or Patients With Significant Comorbidities Ineligible for Standard Chemotherapy
A Phase 2 Open-label Study of Brentuximab Vedotin in Front-line Therapy of Hodgkin Lymphoma (HL) an dCD30-expressing Peripheral T-cell Lymphoma (PTCL) in Older Patients or Patients With Significant Comorbidities Ineligible for Standard Chemotherapy
Enrollment Status: Completed
Publish Date: June 11, 2024
Intervention Type: Drug
Study Drugs: Brentuximab, Bendamustine, Dacarbazine, Nivolumab
Study Phase: Phase 2
Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (PROOF 302)
Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (PROOF 302)
Enrollment Status: Terminated
Publish Date: March 13, 2024
Intervention Type: Drug
Study Drug: Infigratinib
Study Phase: Phase 3
View 3 Less Clinical Trials

3 Total Publications

The Rapid Emergence of Novel Therapeutics in Advanced Malignant Melanoma.
The Rapid Emergence of Novel Therapeutics in Advanced Malignant Melanoma.
Journal: Dermatology and therapy
Published: June 03, 2015
Similar Doctors
Expertise in
26
conditions
Expertise in
26
conditions
Referral may be required

Longview Cancer Center Mobile Pet

1300 N 4th St, 
Longview, TX 
 (0.1 miles away)
903-757-2122
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Matei Socoteanu is an Oncologist practicing medicine in Longview, Texas. Dr. Socoteanu is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Lung Cancer, and Paget Disease of the Breast. Dr. Socoteanu is currently accepting new patients.

Expertise in
19
conditions
Expertise in
19
conditions
Referral may be required

Texas Oncology Pharmacy-Longview

1400 N 4th St, 
Longview, TX 
 (0.1 miles away)
903-757-2122
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kavita Nirmal is an Oncologist practicing medicine in Longview, Texas. Dr. Nirmal is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Paget Disease of the Breast, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma. Dr. Nirmal is currently accepting new patients.

Expertise in
16
conditions
Expertise in
16
conditions
Referral may be required

Longview Cancer Center Mobile Pet

1300 N 4th St, 
Longview, TX 
 (0.1 miles away)
972-997-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rama Koya is an Oncologist practicing medicine in Longview, Texas. Dr. Koya is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Colorectal Cancer, Familial Colorectal Cancer, and Pleuropulmonary Blastoma. Dr. Koya is currently accepting new patients.

Frequently Asked Questions about Dr. Lijo John

How do I make an appointment with Dr. Lijo John?

You can book an appointment with Dr. Lijo John by calling their office at 903-757-2122. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Lijo John a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Lijo John is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Lijo John specialize in?

While Dr. Lijo John is a Oncology, they have specific expertise in Lung Cancer, Pleuropulmonary Blastoma, and Familial Colorectal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Lijo John participate in research or clinical trials?

Yes. Dr. Lijo John has published 3 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Lijo John's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Lijo John accept my insurance?

Dr. Lijo John accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 903-757-2122 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. John's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 11 Advanced Conditions
    View All 95 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile